Market closedNon-fractional

iCAD/ICAD

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About iCAD

icad Inc is a medical technology company providing cancer detection and therapy solutions. The Company operates in one segment: Detection. The Detection segment include advanced image analysis and workflow solutions that enable healthcare professionals to serve patients by identifying pathologies, comprehensive range of high-performance, Artificial Intelligence and Computer-Aided Detection (CAD) systems and workflow solutions for 2D and 3D mammography, Magnetic Resonance Imaging and Computed Tomography. The company geographically operates in France, Belgium, Italy, Germany, Switzerland and All other.

Ticker

ICAD

Sector

Healthcare

Trading on

NASDAQ

Industry

Health Care Technology

Headquarters

Nashua, United States

Employees

68

iCAD Metrics

BasicAdvanced
$32M
Market cap
-
P/E ratio
-$0.09
EPS
1.50
Beta
-
Dividend rate
$32M
1.5
4.715
4.35
0.943
1.608
-368.13%
-8.37%
-16.02%
1.732
0.99
1.34
-5.209
7.98%
-83.92%
-17.37%
-35.13%

What the Analysts think about iCAD

Analyst Ratings

Majority rating from 3 analysts.
Buy

iCAD Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-24.48% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$4.9M
4.26%
Net income
-$1.2M
-160.00%
Profit margin
-24.48%
-157.53%

iCAD Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 21.05%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.07
-$0.05
$0.05
-$0.05
-
Expected
-$0.11
-$0.09
-$0.05
-$0.06
-$0.07
Surprise
-36.36%
-44.44%
-193.75%
-21.05%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for iCAD stock?

iCAD (ICAD) has a market cap of $32M as of July 06, 2024.

What is the P/E ratio for iCAD stock?

The price to earnings (P/E) ratio for iCAD (ICAD) stock is 0 as of July 06, 2024.

Does iCAD stock pay dividends?

No, iCAD (ICAD) stock does not pay dividends to its shareholders as of July 06, 2024.

When is the next iCAD dividend payment date?

iCAD (ICAD) stock does not pay dividends to its shareholders.

What is the beta indicator for iCAD?

iCAD (ICAD) has a beta rating of 1.5. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

Buy or sell iCAD stock

Buy or sell iCAD stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing